• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Deciphering the lung microbiota in COVID-19 patients: insights from culture analysis, FilmArray pneumonia panel, ventilation impact, and

tetano

Editor, Senior Moderator
Sci Rep


. 2024 Dec 3;14(1):30035.
doi: 10.1038/s41598-024-81738-8. Deciphering the lung microbiota in COVID-19 patients: insights from culture analysis, FilmArray pneumonia panel, ventilation impact, and mortality trends

Francisco José Molina[SUP] 1 2 [/SUP], Luz Elena Botero[SUP] 3 [/SUP], Juan Pablo Isaza[SUP] 3 [/SUP], Luz Elena Cano[SUP] 3 4 [/SUP], Lucelly López[SUP] 3 [/SUP], Luis Valdés[SUP] 3 [/SUP], Angela J Arévalo Arbeláez[SUP] 5 [/SUP], Isabel Moreno[SUP] 5 [/SUP], Laura S Pérez Restrepo[SUP] 5 [/SUP], Jaime Usuga[SUP] 5 [/SUP], Karl Ciuoderis[SUP] 5 [/SUP], Juan Pablo Hernandez[SUP] 5 [/SUP], Rubén López-Aladid[SUP] 6 [/SUP], Laia Fernández[SUP] 6 7 [/SUP], Antoni Torres[SUP] 6 7 [/SUP]



Affiliations
Abstract

Few studies have analyzed the role of the lung microbiome in the diagnosis of pulmonary coinfection in ventilated ICU COVID-19 patients. We characterized the lung microbiota in COVID-19 patients with severe pneumonia on invasive mechanical ventilation using full-length 16S rRNA gene sequencing and established its relationship with coinfections, mortality, and the need for mechanical ventilation for more than 7 days. This study included 67 COVID-19 ICU patients. DNA extracted from mini-bronchoalveolar lavage fluid and endotracheal aspirates was amplified by PCR with specific 16S primers (27F and 1492R). General and relative bacterial abundance analysis was also conducted. Alpha diversity was measured by the Shannon and Simpson indices, and differences in the microbiota were established using beta diversity. A linear discriminant analysis (LDA) effect size algorithm was implemented to describe biomarkers. Streptococcus spp. represented 51% of the overall microbial abundance. There were no differences in alpha diversity between the analyzed variables. There was variation in bacterial composition between samples that had positive and negative cultures. The genera Veillonella sp., Granulicatella sp., Enterococcus sp. and Lactiplantibacillus sp., with LDA scores > 2, were biomarkers associated with negative cultures. Rothia sp., with an LDA score > 2, was a biomarker associated with mortality.


 
Back
Top Bottom